Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.050
0.00 (0.00%)
At close: Jun 18, 2025, 4:00 PM
1.090
+0.040 (3.79%)
After-hours: Jun 18, 2025, 5:21 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $23.28 million as of June 18, 2025. Its market cap has decreased by -88.48% in one year.
Market Cap
23.28M
Enterprise Value
-66.40M
1-Year Change
-88.48%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $23.28M, a decrease of -93.46%. That is a compound annual growth rate of -89.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 23.28M | -64.00% |
| Dec 31, 2024 | 64.67M | -81.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 710.32B |
| Johnson & Johnson | 366.64B |
| Novo Nordisk | 334.60B |
| AbbVie | 327.63B |
| UnitedHealth Group | 280.19B |
| Abbott Laboratories | 230.15B |
| Novartis AG | 229.92B |
| AstraZeneca | 223.18B |